RETACRIT 40,000 UNIT/ML VIAL
FDA nonproprietary name: epoetin alfa-epbx
For 4 mL
Pharmacies pay
$1,792.03 filed
4 × $448.00738 per ML
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-22 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$823.96 filed
4 × $205.99118 per ML, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
0.46× estimated
Medicare paid 54% less than pharmacies pay.
Part D averages every strength and form sold under “Retacrit” / “Epoetin Alfa-Epbx” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-07-22 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$2,065.83 estimated
$1,792.03 + $268.80 (15%) + $5.00 fee per fill = $2,065.83
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-07-22 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
RETACRIT 40,000 UNIT/ML VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as epoetin alfa-epbx, under the trade name “RETACRIT”.
FDA gives its dosage form as injection, solution and its route as intravenous; subcutaneous.
The labeler, the company named on the label, is Pfizer Laboratories Div Pfizer Inc.
FDA’s Established Pharmacologic Class for it is Erythropoiesis-stimulating Agent.
The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 00069-1309-04.
NADAC classes it in its brand rate-setting class B-BIO, and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $1,792.03 for 4 mL (4 × $448.00738 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-07-22. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 4, carried forward from the previous file; 5, calculated based on package size.
This NDC’s NADAC was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: it took effect on 2026-07-22. The file is new; the price is not.
What NADAC measures · NADAC explanation codes · Carried-forward prices
The NDC
- 00069-1309-04 · Pfizer Laboratories Div Pfizer Inc · $448.00738 per ML · eff. 2026-07-22 filed carried forward
Other strengths, forms and brands
3 other products in the NADAC file share the FDA nonproprietary name epoetin alfa-epbx with RETACRIT 40,000 UNIT/ML VIAL.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| RETACRIT 2,000 UNIT/ML VIAL | $22.52274 per ML filed | $205.99118 per ML filed |
| RETACRIT 10,000 UNIT/ML VIAL | $112.68282 per ML filed | $205.99118 per ML filed |
| RETACRIT 20,000 UNIT/ML VIAL | $224.78764 per ML filed | $205.99118 per ML filed |
| RETACRIT 40,000 UNIT/ML VIAL this page | $448.00738 per ML filed | $205.99118 per ML filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-01, 2026-07-22 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
Its NADAC price is $448.00738 per ML filed.
Of the 13 other products in FDA’s Erythropoiesis-stimulating Agent class priced per ML, 4 have a higher middle NADAC price and 9 a lower one. The one in the middle is RETACRIT 20,000 UNIT/ML VIAL, at $224.78764 per ML filed (eff. 2026-07-01).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-01, 2026-07-22 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $823.96 for 4 mL, at an average of $205.99118 per ML in 2024 (2024-01-01 to 2024-12-31) for “Retacrit” and “Epoetin Alfa-Epbx”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 47,809 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 4 mL? Is it lower than what I would pay through my insurance?
- How much is in the package I am getting? This page uses 4 mL; your package may hold a different amount.
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for RETACRIT 40,000 UNIT/ML VIAL labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Retacrit / Epoetin Alfa-Epbx: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on brand name.
- Why does this page start at 4 mL?
- NADAC prices this product per ML. The FDA NDC Directory’s package description gives 4 mL in one package for this product’s NDC (“4 VIAL, SINGLE-DOSE in 1 CARTON (0069-1309-04) / 1 mL in 1 VIAL, SINGLE-DOSE (0069-1309-01)”), so the card starts at one package: 4 ML. Change it to match your prescription.